Oncotarget

Research Papers:

HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer

Zhixiong Dong, Yang Yang, Shuxia Liu, Jun Lu, Baiqu Huang and Yu Zhang _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2018; 9:512-523. https://doi.org/10.18632/oncotarget.23070

Metrics: PDF 1838 views  |   HTML 2835 views  |   ?  


Abstract

Zhixiong Dong1,2,*, Yang Yang1,4,*, Shuxia Liu3, Jun Lu1, Baiqu Huang1 and Yu Zhang1

1Institute of Genetics and Cytology, The Key Laboratory of Molecular Epigenetic of Ministry of Education (MOE), Northeast Normal University, Changchun 130024, China

2Tianjin Key Laboratory of Animal and Plant Resistance, College of Life Sciences, Tianjin Normal University, Tianjin 300387, China

3The Key Laboratory of Polyoxometalates Science of Ministry of Education (MOE), College of Chemistry, Northeast Normal University, Changchun 130024, China

4Department of Biochemistry and Molecular Biology, Beijing Normal University, Beijing Key Laboratory, Beijing 100875, China

*These authors contributed equally to this work

Correspondence to:

Yu Zhang, email: [email protected]

Keywords: PAC-320; HDAC inhibitor; prostate tumor; apoptosis

Received: August 08, 2017     Accepted: November 14, 2017     Published: December 08, 2017

ABSTRACT

HDAC inhibitors (HDACis) have been demonstrated with profound antiproliferative activities in various tumor types. Previously, we screened several polyoxometalate HDACis based on our p21 luciferase promoter system and demonstrated that such HDACis have antitumor activity. Here, we further investigate the antitumor mechanism of PAC-320, a compound among the polyoxometalates, in human prostate cancer. We demonstrate that PAC-320 is a broad-spectrum HDACi and could inhibit growth of prostate cancer cells in vitro and in vivo. Furthermore, we find that PAC-320 induces cell cycle arrest at G2/M phase and apoptosis. Mechanically, PAC-320 induced cell cycle arrest is associated with an increase of p21 and decrease of cyclin A and cyclin B1, while PAC-320 induced apoptosis is mediated through mitochondria apoptotic pathway and is closely associated with increase of BH3-only proteins Noxa and Hrk. Meanwhile, we demonstrate that p38 MAPK pathway is involved in PAC-320 induced antiproliferative activities in prostate cancer. Taken together, our data indicates that PAC-320 has potent prostate cancer inhibitory activity in vitro and in vivo, which is mediated by G2/M cell cycle arrest and apoptosis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23070